GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is currently emerging as a major focus in healthcare investigation, largely due to its impressive impact on managing conditions such as type 2 diabetes and obesity. Ongoing trials have shown that beyond glucose management, GLP-1 drugs of